Performance of IPOs priced year to date may provide direction for the rest of the year. Through May 31, 76 IPOs have priced producing returns of 24% from the IPO price, mostly from the first day pop.
Fully 57% of the IPOs have been in the biotech/healthcare and technology sectors, split evenly. While the biotechs were up 20%, slightly less than the IPO average, the technology sector averaged 45%, the best sector performance for the period.
| What 2018's IPOs Tell Us About 2H18 | ||
|---|---|---|
| No. of Deals | YTD Performance | |
| All IPOs | 76 | 24.2% |
| Biotech | 24 | 20.2% |
| Technology | 23 | 44.6% |
Sign up for a free trial of our premium platform, IPO Pro. Follow us on Twitter (@IPOtweet) and register for our updates on the IPO market.
A closer look at the contributions tells a more interesting story...
To read the full market commentary, sign up for a free trial of IPO Pro, the single most effective IPO investing platform you'll ever need.
